Interim analysis and sample size reassessment

被引:44
作者
Posch, M [1 ]
Bauer, P [1 ]
机构
[1] Univ Vienna, Dept Med Stat, A-1090 Vienna, Austria
关键词
adaptive two-stage designs; combination tests; conditional power; midtrial modification; sample size reassessment;
D O I
10.1111/j.0006-341X.2000.01170.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This article deals with sample size reassessment for adaptive two-stage designs based on conditional power arguments utilizing the variability observed at the first stage. Fisher's product test for the p-values from the disjoint samples at the two stages is considered in detail for the comparison of the means of two normal populations. We show that stopping rules allowing for the early acceptance of the null hypothesis that are optimal with respect to the average sample size may lead to a severe decrease of the overall power if the sample size is a priori underestimated. This problem can be overcome by choosing designs with low probabilities of early acceptance or by midtrial adaptations of the early acceptance boundary using the variability observed in the first stage. This modified procedure is negligibly anticonservative and preserves the power.
引用
收藏
页码:1170 / 1176
页数:7
相关论文
共 25 条
[1]   A simulation program for adaptive two stage designs [J].
Bauer, M ;
Bauer, P ;
Budde, M .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1998, 26 (03) :351-371
[2]   AN ADAPTIVE METHOD FOR ESTABLISHING A DOSE-RESPONSE RELATIONSHIP [J].
BAUER, P ;
ROHMEL, J .
STATISTICS IN MEDICINE, 1995, 14 (14) :1595-1607
[3]   EVALUATION OF EXPERIMENTS WITH ADAPTIVE INTERIM ANALYSES [J].
BAUER, P ;
KOHNE, K .
BIOMETRICS, 1994, 50 (04) :1029-1041
[4]   INTERNAL PILOT-STUDIES FOR ESTIMATING SAMPLE-SIZE [J].
BIRKETT, MA ;
DAY, SJ .
STATISTICS IN MEDICINE, 1994, 13 (23-24) :2455-2463
[5]   OPTIMAL RESTRICTED 2-STAGE DESIGNS [J].
CASE, LD ;
MORGAN, TM ;
DAVIS, CE .
CONTROLLED CLINICAL TRIALS, 1987, 8 (02) :146-156
[6]  
Coffey CS, 1999, STAT MED, V18, P1199, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1199::AID-SIM124>3.0.CO
[7]  
2-0
[8]   Modification of sample size in group sequential clinical trials [J].
Cui, L ;
Hung, HMJ ;
Wang, SJ .
BIOMETRICS, 1999, 55 (03) :853-857
[9]  
Hauschke D, 1999, STAT MED, V18, P93, DOI 10.1002/(SICI)1097-0258(19990115)18:1<93::AID-SIM992>3.0.CO
[10]  
2-8